Ironwood Pharmaceuticals, Inc. (IRWD)
4.13
-0.11
(-2.59%)
USD |
NASDAQ |
Aug 28, 16:00
4.125
0.00 (0.00%)
After-Hours: 20:00
Ironwood Pharmaceuticals Free Cash Flow : 185.55M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 185.55M |
| March 31, 2026 | 112.21M |
| December 31, 2025 | 127.01M |
| September 30, 2025 | 67.65M |
| June 30, 2025 | 29.94M |
| March 31, 2025 | 78.41M |
| December 31, 2024 | 103.41M |
| September 30, 2024 | 123.82M |
| June 30, 2024 | 146.36M |
| March 31, 2024 | 147.91M |
| December 31, 2023 | 183.15M |
| September 30, 2023 | 226.74M |
| June 30, 2023 | 263.36M |
| March 31, 2023 | 289.67M |
| December 31, 2022 | 273.63M |
| September 30, 2022 | 258.86M |
| June 30, 2022 | 264.76M |
| March 31, 2022 | 252.05M |
| December 31, 2021 | 261.63M |
| September 30, 2021 | 248.68M |
| June 30, 2021 | 227.38M |
| March 31, 2021 | 198.52M |
| December 31, 2020 | 166.99M |
| September 30, 2020 | 140.42M |
| June 30, 2020 | 118.48M |
| Date | Value |
|---|---|
| March 31, 2020 | 89.53M |
| December 31, 2019 | 4.98M |
| September 30, 2019 | -10.91M |
| June 30, 2019 | -67.83M |
| March 31, 2019 | -81.22M |
| December 31, 2018 | -71.23M |
| September 30, 2018 | -89.28M |
| June 30, 2018 | -96.76M |
| March 31, 2018 | -107.29M |
| December 31, 2017 | -103.77M |
| September 30, 2017 | -214.88M |
| June 30, 2017 | -183.70M |
| March 31, 2017 | -157.92M |
| December 31, 2016 | -129.88M |
| September 30, 2016 | -29.31M |
| June 30, 2016 | -54.42M |
| March 31, 2016 | -73.45M |
| December 31, 2015 | -110.38M |
| September 30, 2015 | -114.65M |
| June 30, 2015 | -127.16M |
| March 31, 2015 | -137.69M |
| December 31, 2014 | -159.11M |
| September 30, 2014 | -181.08M |
| June 30, 2014 | -200.36M |
| March 31, 2014 | -245.52M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Rigel Pharmaceuticals, Inc. | 9.042M |
| AbbVie, Inc. | 18.21B |
| Marker Therapeutics, Inc. | -9.756M |
| Theriva Biologics, Inc. | -12.76M |
| Fortress Biotech, Inc. | 120.28M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 58.28M |
| Cash from Financing (Quarterly) | -199.70M |
| Free Cash Flow Per Share (Quarterly) | 0.3486 |
| Free Cash Flow to Equity (Quarterly) | 258.77M |
| Free Cash Flow to Firm (Quarterly) | 63.29M |
| Free Cash Flow Yield | 26.66% |